Drugs Approved for Acute Lymphoblastic Leukemia (ALL)
- Arranon (Nelarabine)
- Asparaginase Erwinia Chrysanthemi
- Asparaginase Erwinia Chrysanthemi (Recombinant)-rywn
- Asparlas (Calaspargase Pegol-mknl)
- Aucatzyl (Obecabtagene Autoleucel)
- Besponsa (Inotuzumab Ozogamicin)
- Blinatumomab
- Blincyto (Blinatumomab)
- Calaspargase Pegol-mknl
- Clofarabine
- Clolar (Clofarabine)
- Cyclophosphamide
- Cytarabine
- Dasatinib
- Daunorubicin Hydrochloride
- Dexamethasone
- Doxorubicin Hydrochloride
- Erwinaze (Asparaginase Erwinia Chrysanthemi)
- Gleevec (Imatinib Mesylate)
- Iclusig (Ponatinib Hydrochloride)
- Inotuzumab Ozogamicin
- Imatinib Mesylate
- Imkeldi (Imatinib Mesylate)
- Kymriah (Tisagenlecleucel)
- Mercaptopurine
- Methotrexate Sodium
- Nelarabine
- Obecabtagene Autoleucel
- Oncaspar (Pegaspargase)
- Pemazyre (Pemigatinib)
- Pemigatinib
- Pegaspargase
- Ponatinib Hydrochloride
- Prednisone
- Purinethol (Mercaptopurine)
- Purixan (Mercaptopurine)
- Revuforj (Revumenib Citrate)
- Revumenib Citrate
- Rituxan (Rituximab)
- Rituximab
- Rylaze (Asparaginase Erwinia Chrysanthemi [Recombinant]-rywn)
- Sprycel (Dasatinib)
- Tisagenlecleucel
- Trexall (Methotrexate Sodium)
- Vincristine Sulfate
Drug Combinations Used in Acute Lymphoblastic Leukemia (ALL)
Drugs Approved for Acute Myeloid Leukemia (AML)
- Arsenic Trioxide
- Azacitidine
- Cyclophosphamide
- Cytarabine
- Daunorubicin Hydrochloride
- Daunorubicin Hydrochloride and Cytarabine Liposome
- Daurismo (Glasdegib Maleate)
- Dexamethasone
- Doxorubicin Hydrochloride
- Enasidenib Mesylate
- Gemtuzumab Ozogamicin
- Gilteritinib Fumarate
- Glasdegib Maleate
- Grafapex (Treosulfan)
- Idamycin PFS (Idarubicin Hydrochloride)
- Idarubicin Hydrochloride
- Idhifa (Enasidenib Mesylate)
- Ivosidenib
- Midostaurin
- Mitoxantrone Hydrochloride
- Mylotarg (Gemtuzumab Ozogamicin)
- Olutasidenib
- Onureg (Azacitidine)
- Pemazyre (Pemigatinib)
- Pemigatinib
- Prednisone
- Quizartinib Dihydrochloride
- Revuforj (Revumenib Citrate)
- Revumenib Citrate
- Rezlidhia (Olutasidenib)
- Rydapt (Midostaurin)
- Tabloid (Thioguanine)
- Thioguanine
- Tibsovo (Ivosidenib)
- Tisagenlecleucel (Kymriah)
- Treosulfan
- Trisenox (Arsenic Trioxide)
- Vanflyta (Quizartinib Dihydrochloride)
- Venclexta (Venetoclax)
- Venetoclax
- Vincristine Sulfate
- Vyxeos (Daunorubicin Hydrochloride and Cytarabine Liposome)
- Xospata (Gilteritinib Fumarate)
Drug Combinations Used in Acute Myeloid Leukemia (AML)
Drugs Approved for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Drugs Approved for Chronic Lymphocytic Leukemia (CLL)
- Acalabrutinib Maleate Monohydrate
- Alemtuzumab
- Arzerra (Ofatumumab)
- Bendamustine Hydrochloride
- Bendeka (Bendamustine Hydrochloride)
- Breyanzi (Lisocabtagene Maraleucel)
- Brukinsa (Zanubrutinib)
- Calquence (Acalabrutinib Maleate Monohydrate)
- Campath (Alemtuzumab)
- Chlorambucil
- Copiktra (Duvelisib)
- Cyclophosphamide
- Dexamethasone
- Duvelisib
- Fludarabine Phosphate
- Gazyva (Obinutuzumab)
- Ibrutinib
- Idelalisib
- Imbruvica (Ibrutinib)
- Jaypirca (Pirtobrutinib)
- Leukeran (Chlorambucil)
- Lisocabtagene Maraleucel
- Obinutuzumab
- Ofatumumab
- Pirtobrutinib
- Prednisone
- Riabni (Rituximab)
- Rituxan (Rituximab)
- Rituxan Hycela (Rituximab and Hyaluronidase Human)
- Rituximab
- Rituximab and Hyaluronidase Human
- Ruxience (Rituximab)
- Treanda (Bendamustine Hydrochloride)
- Truxima (Rituximab)
- Venclexta (Venetoclax)
- Venetoclax
- Zanubrutinib
- Zydelig (Idelalisib)
Drug Combinations Used in Chronic Lymphocytic Leukemia (CLL)
Drugs Approved for Chronic Myelogenous Leukemia (CML)
- Asciminib Hydrochloride
- Bosulif (Bosutinib)
- Bosutinib
- Busulfan
- Busulfex (Busulfan)
- Cyclophosphamide
- Cytarabine
- Dasatinib
- Dexamethasone
- Gleevec (Imatinib Mesylate)
- Hydrea (Hydroxyurea)
- Hydroxyurea
- Iclusig (Ponatinib Hydrochloride)
- Imatinib Mesylate
- Imkeldi (Imatinib Mesylate)
- Myleran (Busulfan)
- Nilotinib
- Omacetaxine Mepesuccinate
- Ponatinib Hydrochloride
- Scemblix (Asciminib Hydrochloride)
- Sprycel (Dasatinib)
- Synribo (Omacetaxine Mepesuccinate)
- Tasigna (Nilotinib)
Drugs Approved for Hairy Cell Leukemia
Drugs Approved for Mast Cell Leukemia
Drugs Approved for Meningeal Leukemia